With the sequence of the mouse genome essentially complete, the new long-term goal is to assign function to the genes identified. Knowing the functions for the complete set of genes in a model mammalian organism has obvious biological significance. The value of this information for human health and medicine is in its potential to aid in the discovery of new disease-related genes, to provide the tools needed to create new models for human disease, and to ? ? ? help validate new drug targets. The Knock-Out Mouse Project (KOMP) has set the goal of creating a comprehensive resource of mouse mutations in which every gene in the mouse genome has been knocked out by a null mutation marked with a reporter system. To apply the power of targeted gene modification on the ambitious scale proposed by the KOMP demands significant technological improvements in throughput and capacity. We propose to use our high-throughput and validated VelociGene technology to create a library of 10,000 targeting vectors and a collection of 10,000 mouse ES cell clones, each carrying a definitive null mutation for a unique protein-coding gene. To meet our ambitious production targets, we describe a research plan organized to achieve the following specific aims: ? 1. Construct a library of BAC-based targeting vectors (BacVecs) designed to create definitive null mutations(in most cases, deletions of the entire coding region) and incorporating a lacZ reporter of high utility for 10,000 mouse protein-coding genes. ? 2. Using the BacVecs produced by Specific Aim 1, create a collection of C57BL/6 ES cell clones each ? having a defined null allele and an incorporated reporter for each of 10,000 mouse protein-coding genes,and generate mice from 5% of these ES cell clones (500 mouse lines total) as a test of the collection for germ-line transmission. ? 3. Create a library of BAC-containing recombination-ready E. coli clones (from Specific Aim 1) that can be used to engineer any desired additional allele (conditionals, replacements, and point mutations)for each of the 10,000 protein coding regions. ? 4. Provide a database that allows real-time access to all production data and materials linked to the targetgene as the reference point. ? 5. Devise a computer program that automates the design of null alleles. ? 6. Robotically automate the preparation and quality control of BACs and BacVecs. ? 7. Robotically automate the picking of ES cell clones and their expansion, storage and retrieval. ? 8. Reduce the unit cost of our automated screening by decreasing reagent use and increase throughput and efficiency by improvements in automated data analysis, targeted clone scoring, and database entry. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01HG004085-03
Application #
7496638
Study Section
Special Emphasis Panel (ZHG1-HGR-N (M1))
Program Officer
Fletcher, Colin F
Project Start
2006-09-07
Project End
2011-06-30
Budget Start
2008-09-01
Budget End
2009-06-30
Support Year
3
Fiscal Year
2008
Total Cost
$5,172,790
Indirect Cost
Name
Regeneron Pharmaceuticals, Inc.
Department
Type
DUNS #
194873139
City
Tarrytown
State
NY
Country
United States
Zip Code
10591
Inloes, Jordon M; Jing, Hui; Cravatt, Benjamin F (2018) The Spastic Paraplegia-Associated Phospholipase DDHD1 Is a Primary Brain Phosphatidylinositol Lipase. Biochemistry 57:5759-5767
Regensburger, Martin; Prots, Iryna; Reimer, Dorothea et al. (2018) Impact of Swiprosin-1/Efhd2 on Adult Hippocampal Neurogenesis. Stem Cell Reports 10:347-355
Stawowczyk, Marcin; Naseem, Shamoon; Montoya, Valeria et al. (2018) Pathogenic Effects of IFIT2 and Interferon-? during Fatal Systemic Candida albicans Infection. MBio 9:
Zamarbide, Marta; Oaks, Adam W; Pond, Heather L et al. (2018) Loss of the Intellectual Disability and Autism GeneCc2d1aand Its HomologCc2d1bDifferentially Affect Spatial Memory, Anxiety, and Hyperactivity. Front Genet 9:65
Tassi, Elena; Garman, Khalid A; Schmidt, Marcel O et al. (2018) Fibroblast Growth Factor Binding Protein 3 (FGFBP3) impacts carbohydrate and lipid metabolism. Sci Rep 8:15973
Schmitt, Charlotte C; Aranias, Thomas; Viel, Thomas et al. (2017) Intestinal invalidation of the glucose transporter GLUT2 delays tissue distribution of glucose and reveals an unexpected role in gut homeostasis. Mol Metab 6:61-72
Tran, Melanie; Lee, Sang-Min; Shin, Dong-Ju et al. (2017) Loss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASH. JCI Insight 2:
Lange, Lisette; Marks, Matthias; Liu, Jinhua et al. (2017) Patterning and gastrulation defects caused by the tw18 lethal are due to loss of Ppp2r1a. Biol Open 6:752-764
Calabrese, Gina M; Mesner, Larry D; Stains, Joseph P et al. (2017) Integrating GWAS and Co-expression Network Data Identifies Bone Mineral Density Genes SPTBN1 and MARK3 and an Osteoblast Functional Module. Cell Syst 4:46-59.e4
Harms, Robert Z; Creer, Austin J; Lorenzo-Arteaga, Kristina M et al. (2017) Interleukin (IL)-18 Binding Protein Deficiency Disrupts Natural Killer Cell Maturation and Diminishes Circulating IL-18. Front Immunol 8:1020

Showing the most recent 10 out of 56 publications